Walks for LGS Fuel Bold Plan to Overhaul Rare Epilepsy Care

SAN DIEGO, CA – April 06, 2026 – Across the nation this month, communities are gathering for a series of walks with a profound purpose. The 'Walks for LGS Research,' organized by the Lennox-Gastaut Syndrome (LGS) Foundation, are mobilizing families, researchers, and clinicians under a single banner: "Stepping Together for a Breakthrough." This grassroots movement is the financial engine for an ambitious strategy to confront one of the most severe and treatment-resistant forms of childhood-onset epilepsy.

Lennox-Gastaut Syndrome affects more than one million people worldwide, trapping them in a relentless cycle of debilitating seizures. It is a severe developmental epileptic encephalopathy, defined not just by multiple seizure types but also by significant developmental delays and cognitive impairment. For decades, the path for those affected has been fraught with uncertainty, delayed diagnoses, and a frustrating lack of therapies that do more than temporarily manage symptoms. The funds raised by these community walks are aimed directly at dismantling these long-standing barriers.

The Long Road of Lennox-Gastaut Syndrome

For families navigating an LGS diagnosis, the journey is often a grueling odyssey of trial and error. The emotional toll is captured in the words of Tricia, mother to Mason, who lives with the condition. "We threw ourselves with every ounce of energy we could find into therapies and medical treatments," she shared. "Countless medications were tried – many that had side effects that made us feel like we were putting out his beautiful light. So many failed to help at all. Some helped for a while then stopped."

This experience is tragically common. Research shows that the diagnostic process itself is a major hurdle, with studies indicating that for over half of patients, the time from the first seizure to an accurate LGS diagnosis can stretch to three years or more. During this critical window, children often contend with uncontrolled seizures and accumulating developmental delays. Cognitive impairment is nearly universal, affecting approximately 90% of children with LGS, and the condition persists into adulthood in almost all cases.

The burden extends deep into the family unit. Caregivers face constant anxiety over seizures, potential injuries, and the risk of Sudden Unexpected Death in Epilepsy (SUDEP), which is significantly higher in this population. The demands of care impact every facet of life, leading to profound emotional, physical, and financial distress. Studies have documented high rates of major depressive disorder and PTSD among parents of children with LGS, who report relentless stress and a struggle to balance the needs of their entire family.

A Strategic Blueprint for Breakthroughs

In response to this crisis, the LGS Foundation has architected the 'Powering Breakthroughs: Tackling The 3 Grand Challenges in LGS' initiative. This is not merely a research fund but a comprehensive, long-term strategy designed to systematically transform the LGS landscape. Proceeds from the April walks directly fuel this multi-pronged assault on the disease.

The initiative is built on three strategic pillars:

• Precision Diagnoses: Directly addressing the painful diagnostic delays, this challenge aims to shorten the time from first seizure to accurate diagnosis from years to mere months. By funding critical biomarker studies and establishing a national early-diagnosis network, the Foundation seeks to give children and families answers sooner. Earlier identification not only improves developmental outcomes but also streamlines the entire research pipeline by enabling more efficient clinical trial enrollment.

• Precision Treatments: LGS is notoriously treatment-resistant, with many of the six FDA-approved drugs eventually losing efficacy. This Grand Challenge sets a bold goal: to catalyze at least two disease-modifying or disease-reversing therapies into clinical trials within the next decade. By funding innovative science and fostering collaboration among research consortia and industry partners, the Foundation is acting as a strategic catalyst, ensuring that research priorities are aligned with the outcomes that matter most to patients.

• Whole-Life Care: Recognizing that LGS is a lifelong condition, this pillar focuses on addressing systemic inequities in healthcare access and quality. The strategy involves expanding the network of recognized LGS specialty clinics and implementing a unified outcomes registry. This real-world data infrastructure is a powerful tool, providing families with insights into best practices while offering researchers and pharmaceutical companies invaluable data on long-term treatment effects and patient needs.

Patient-Driven Science in Action

At the heart of the LGS Foundation’s model is a core principle: "Nothing about us, without us!" The organization is pioneering a patient-driven approach to science that empowers the very community it serves. This philosophy ensures that the research being funded is not just scientifically interesting but directly relevant to improving the quality of life for those living with LGS.

Initiatives like the 'Learn From Every Patient Database' allow families to contribute their data directly, turning personal experience into a powerful resource for discovery. This collaborative spirit extends to the Foundation’s partnerships, which include a vast network of academic centers, professional societies, and biotech innovators, all aligned around a common goal.

The effectiveness of this model is bolstered by the Foundation's commitment to financial transparency and efficiency. With top ratings from charity evaluators like Charity Navigator (Four-Star) and GuideStar (Platinum), donors can be confident that their contributions are making a direct impact. Since its inception, the organization has directed over $2.4 million into LGS research, a figure that has correlated with a more than threefold increase in the annual number of scientific publications on LGS.

The walks happening this month are more than just a fundraiser; they are a demonstration of collective will. Each step taken on paths and in parks across the country represents a tangible investment in a future where families like Mason’s are given more than guesswork. They are walking for real answers, effective treatments, and the comprehensive support they have long deserved.